[Federal Register Volume 83, Number 109 (Wednesday, June 6, 2018)]
[Notices]
[Pages 26289-26290]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-12082]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-18-0920; Docket No. CDC-2018-0053]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a proposed 
information collection project titled Data Collection Through Web Based 
Surveys for Evaluating Act Against AIDS Social Marketing Campaign 
Phases Targeting Consumers which includes web surveys to test campaign 
messaging.

DATES: CDC must receive written comments on or before August 6, 2018.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2018-
0053 by any of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to Regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (regulations.gov) or by U.S. mail to the address listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Leroy A. Richardson, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected; and
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses.
    5. Assess information collection costs.

Proposed Project

    Data Collection Through Web Based Surveys for Evaluating Act 
Against AIDS Social Marketing Campaign Phases Targeting Consumers--
Extension--National Center for HIV/AIDS, Viral Hepatitis, STD and TB 
Prevention (NCHHSTP, Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    In response to the continued HIV epidemic in our country, CDC 
launched Act Against AIDS (AAA), a multifaceted communication campaign 
to reduce HIV incidence in the United States in 2009. CDC has released 
the campaign in phases, with some of the phases running concurrently. 
Each phase of the campaign uses mass media and direct-to-consumer 
channels to deliver messages. Some campaigns provide basic education 
and increase awareness of HIV/AIDS among the general public whereas 
others emphasize HIV prevention and testing among specific subgroups or 
communities at greatest risk of infection. CDC will also develop new 
messages to address changes in prevention science and subpopulations 
affected by HIV. The proposed study will assess the effectiveness of 
these social marketing messages aimed at increasing HIV/AIDS awareness, 
increasing prevention behaviors, and improving HIV testing rates among 
consumers.
    This extension of an ongoing study will allow for continued 
evaluation of the effectiveness of AAA social marketing campaign 
through surveys with consumers. A total of 10,750 respondents were 
approved for the previously renewed generic ICR (0920-0920) and since 
the approval date, 4,305 respondents were surveyed under the GenIC, 
``Development of Messages for

[[Page 26290]]

the Act Against AIDS National Testing''. The information collected from 
these data collections was used to evaluate a specific AAA campaign 
phase. We are requesting the same amount of time to continue surveying 
AAA target audiences as new phases are developed.
    Through this extension, we plan to reach the remaining approved 
6,445 respondents. To obtain the remaining respondents, we anticipate 
screening approximately 32,220 individuals. Depending on the target 
audience for the campaign phase, the study screener will vary. The 
study screener may address one or more of the following items: Race/
ethnicity, sexual behavior, sexual orientation, gender identity, HIV 
testing history, HIV status, and injection drug use. Each survey will 
have a core set of items asked in all rounds, as well as a module of 
questions relating to specific AAA phases and activities.
    Respondents will be recruited through national opt-in email lists, 
the internet, and external partnerships with community-based and 
membership organizations that work with or represent individuals from 
targeted populations (e.g., National Urban League, the National Medical 
Association). Respondents will self-administer the survey at home on 
personal computers. There is no cost to the respondents other than 
their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondents           Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
Individuals (male and female)   Study Screener..          10,740               1            2/60             358
 aged 18 years and older.       Survey..........           2,148               1           30/60           1,074
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............           1,432
----------------------------------------------------------------------------------------------------------------



Jeffrey M. Zirger,
Acting Chief, Information Collection Review Office, Office of 
Scientific Integrity, Office of the Associate Director for Science, 
Office of the Director, Centers for Disease Control and Prevention.
[FR Doc. 2018-12082 Filed 6-5-18; 8:45 am]
BILLING CODE 4163-18-P